Correlation of the epitopes defined by anti-CD26 mAbs and CD26 function

Molecular Immunology

Volumn 35, Issue 1, 1998, Pages 13-21

  Dong, R P ^a   Tachibana, K ^a   Hegen, M ^a   Scharpe S ^b   Cho, D ^a   Schlossman, S F ^a   Morimoto, C ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

ADA binding protein; CD26; Costimulation; DPPIV; MAb

Indexed keywords

DIPEPTIDYL PEPTIDASE IV; EPITOPE; MONOCLONAL ANTIBODY;

AMINO ACID SEQUENCE; ANTIGEN ANTIBODY REACTION; ANTIGEN BINDING; ARTICLE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; STRUCTURE ACTIVITY RELATION; T LYMPHOCYTE ACTIVATION;

EID: 0031838052     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-5890(98)00015-7     Document Type: Article

References (26)

1. Fox, D.A., Hussey, R.E., Fitzgerald, K.A., Acuto, O., Poole, C., Palley, L., Daley, J.F., Schlossman, S.F., Reinherz, E.L., 1984. Tal, a novel 105 kD human T-cell activation antigen defined by a monoclonal antibody. J. Immunol. 133, 1250-1256.
2. Dang, N.H., Hafler, D.A., Schlossman, S.F., Breitmeyer, J.B., 1990. FcR-mediated crosslinking of Ta1 (CDw26). induces human T lymphocyte activation. Cellul. Immunol. 125, 42-57.
3. Dang, N.H., Torimoto, Y., Deusch, K., Schlossman, S.F., Morimoto, C., 1990a. Comitogenic effect of solid-phase immobilized anti-1F7 on human CD4 T-cell activation via CD3 and CD2 pathways. Immunol. 144, 4092-4100.
4. Dang, N.H., Torimoto, Y., Schlossman, S.F., Morimoto, C., 1990b. Human CD4 helper T-cell activation, functional involvement of two distinct collagen receptors, 1F7 and VLA integrin family. J. Exp. Med.. 172, 649-652.
5. Dang, N.H., Torimoto, Y., Sugita, K., Daley, J.F., Schow, P., Prado, C., Schlossman, S.F., Morimoto, C., 1990c. Cell surface modulation of CD26 by anti-IF7 monoclonal antibody. J. Immunol. 145, 3963-3971.
6. De Meester, I., Vanham, G., Kestens, L., Vanhoof, G., Bosmans, E., Gigase, P., Scharpe, S., 1994. Binding of adenosine deaminase to the lymphocyte surface via CD26. Eur. J. Immunol. 24, 566-570.
7. Dinjens, W.N.M., ten Kate, J., Wijnen, J.T., van der Linden, E.P.M., Beek, C.J.L., Lenders, M.-H.J.H., Khan, P.M., Bosman, F.T., 1989. Distribution of adenosine deaminase-complexing protein in murine tissues. J. Biol. Chem. 264, 19215-19220.
8. Dong, R.-P., Kameoka, J., Hegen, M., Tanaka, T., Xu, Y., Schlossman, S.F., Morimoto, C., 1996. Characterization of adenosine deaminase binding to human CD26 on T cells and its biologic role in immune response. J. Immunol. 156, 1349-1355.
9. Duke-Cohan, J.S., Morimoto, C., Rocker, J.A., Schlossman, S.F., 1995. A novel form of dipeptidylpeptidase IV found in human serum. Biol. Chem. 270, 14107-14114.
10. Fleischer, B., 1987. A novel pathway of human T-cell activation via a 103 kD T-cell activation antigen. J. Immunol. 138, 1346-1350.
11. Fleischer, B., 1994. CD26, a surface protease involved in T-cell activation. Immunol. Today 15, 180-184.
12. Gutheil, W.G., Subramanyam, M., Flentke, G.R., Sanford, D.G., Munoz, E., Huber, B.T., Bachovchin, W.W., 1994. Human immunodeficiency virus 1 Tat binds to dipeptidyl aminopeptidase IV (CD26), a possible mechanism for Tat's immunosuppressive activity. Proc. Natl. Acad. Sci. U.S.A. 91, 6594-6598.
13. Hegen, M., Kameoka, J., Dong, R.-P., Schlossman, S.F., Morimoto, C., 1997. Cross-linking of CD26 by antibody induces tyrosine phosphorylation and activation of mitogen-activated protein kinase. Immunology. 90, 257-264.
14. Hegen, M., Niedobitek, G., Klein, C.E., Stein, H., Fleischer, B., 1990. The T-cell triggering molecule Tp 103 is associated with dipeptidyl aminopeptidase IV activity. J. Immunol. 144, 2908-2914.
15. Kameoka, J., Tanaka, T., Nojima, Y., Schlossman, S.F., Morimoto, C., 1993. Direct association of adenosine deaminase with a T-cell activation antigen, CD26. Science. 261, 466-469.
16. Loster, K., Zeilinger, K., Schuppan, D., Reutter, W., 1995. The cysteine-rich region of dipeptidyl peptidase IV (CD26) is the collagen-binding site. Biochem & Biophys Res Commun. 217, 341-348.
17. Morimoto, C., Schlossman, S.F., 1994. CD26, a key costimulatory molecule on CD4 memory T cells. Immunologist. 2, 4-7.
18. Morimoto, C., Torimoto, Y., Levinson, G., Rudd, C.E., Schrieber, M., Dang, N.H., Letvin, N.L., Schlossman, S.F., 1989. IF7, a novel cell surface molecule involved in helper function of CD4 cells. J. Immunol. 143, 3430-3439.
19. Morrison, M.E., Vijayasaradhi, S., Engelstein, D., Albino, A.P., Houghton, A.N., 1993. A marker for neoplastic progression of human melanocytes is a cell surface ectopeptidase. J. Exp. Med. 177, 1135-1143.
20. Schrader, W.P., West, C.A., Miczek, A.D., Norton, E.K., 1990. Characterization of the adenosine deaminase-adenosine deaminase completing protein binding reaction. J. Biol. Chem. 265, 19312-19318.
21. Tanaka, T., Camerini, D., Seed, B., Torimoto, Y., Dang, N.H., Kameoka, J., Dahlberg, H.N., Schlossman, S.F., Morimoto, C., 1992. Cloning and functional expression of the T-cell activation antigen. CD26. J. Immunol. 149, 481-486.
22. Tanaka, T., Kameoka, J., Yaron, A., Schlossman, S.F., Morimoto, C., 1993. The costimulatory activity of the CD26 antigen requires dipeptidyl peptidase IV enzymatic activity. Proc. Natl. Acad. Sci. U.S.A. 90, 4586-4590.
23. Torimoto, T., Dang, N.H., Vivier, E., Tanaka, T., Schlossman, S.F., Morimoto, C., 1991. Coassociation of CD26 (Dipeptidyl peptidase IV). with CD45 on the surface of human T lymphocytes. J. Immunol. 147, 2514-2517.
24. Torimoto, Y., Dang, N.H., Tanaka, T., Prado, C., Schlossman, C.F., Morimoto, C., 1992. Biochemical characterization of CD26 (Dipeptidyl peptidase IV): functional comparison of distinct epitopes recognized by various anti-CD26 monoclonal antibodies. Mol. Immunol. 29, 183-192.
25. Uhner, A.J., Mattern, T., Feller, A.C., Heymann, E., Flad, H., 1990. CD26 antigen is a surface dipeptidyl peptidase IV (DPPIV) as, characterized by monoclonal antibodies clone TII-19-4-7 and 4ELIC7. Scand. J. Immunol. 31, 429-435.
26. Yaron, A., Naider, F., 1993. Proline-dependent structural and biological properties of peptides and proteins. Crit. Rev. Biochem. Mol. Biol. 28, 31-81.